1,567
edits
Line 103: | Line 103: | ||
==Outcomes== | ==Outcomes== | ||
''Comparisons are hydrocortisone vs. placebo'' | |||
''Comparisons are | |||
<!--The usual formatting leaves out the number of events: | <!--The usual formatting leaves out the number of events: | ||
Line 111: | Line 109: | ||
===Primary Outcomes=== | ===Primary Outcomes=== | ||
; Death from Any Cause at 90 Days | |||
: 27.9% vs. 28.8% [OR 0.95, 95% CI 0.82 – 1.10; P = 0.50] | |||
; | ===Secondary Outcomes=== | ||
: | ; Median time to Shock Reversal, days | ||
: 3 (2-5) vs. 4 (2-9) [HR 1.32, 95% CI 1.23 – 1.41; P < 0.001] | |||
; Median time to discharge from the ICU, days(IRQ) | |||
: 10 (5 - 30) vs. 12 (6 - 42) [HR 1.14 (1.06 to 1.23); P < 0.001] | |||
; Median time to cessation of initial mechanical ventilation, days (IQR) | |||
: 6 (3 - 18) vs. 7 (3 - 24) [HR 1.13 (1.05 to 1.22); P < 0.001] | |||
; Blood Transfusions | |||
: 37% vs. 41% [OR 0.82 (0.72 to 0.94); P = 0.004] | |||
; 28 day mortality | |||
: NS | |||
; Recurrence of Shock | |||
: NS | |||
; | ; | ||
Number of days alive and out of the ICU | |||
Number of days alive and out of the hospital | |||
Recurrence of mechanical ventilation | |||
Rate of renal replacement therapy | |||
Incidence of new-onset bacteremia or fungemia | |||
===Subgroup Analysis=== | ===Subgroup Analysis=== |
edits